Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Medicine|May 20, 2021
COVID19 infection in a patient with paroxysmal nocturnal hemoglobinuria: A case reportJuraj Sokol, Frantisek Nehaj, Michal Mokan, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 14, 2017
Thrombin Receptor Agonist Peptide-Induced Platelet Aggregation Is Reduced in Patients Receiving DabigatranFrantisek Nehaj, Juraj Sokol, Michal Mokan, et al.
Journal of Thrombosis and Thrombolysis|July 25, 2018
First evidence: rivaroxaban and apixaban reduce thrombin-dependent platelet aggregationJuraj Sokol, Frantisek Nehaj, Jela Ivankova, et al.
American Journal of Therapeutics|August 4, 2018
Effect of Bisoprolol on the Level of DabigatranFrantisek Nehaj, Juraj Sokol, Jela Ivankova, et al.
Scandinavian Cardiovascular Journal : SCJ|May 30, 2018
Dabigatran affects thrombin-dependent platelet aggregation after a week-long therapyJuraj Sokol, Frantisek Nehaj, Jela Ivankova, et al.
Journal of Thrombosis and Thrombolysis|March 30, 2020
Edoxaban affects TRAP-dependent platelet aggregationFrantisek Nehaj, Juraj Sokol, Jela Ivankova, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 21, 2017
First Evidence: TRAP-Induced Platelet Aggregation Is Reduced in Patients Receiving XabansFrantisek Nehaj, Juraj Sokol, Jela Ivankova, et al.
Biomed Research International|March 17, 2018
Outcomes of Patients with Newly Diagnosed Cardiac Myxoma: A Retrospective Multicentric StudyFrantisek Nehaj, Juraj Sokol, Michal Mokan, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 1, 2021
Impact of Dabigatran Treatment on Rotation ThromboelastometryJuraj Sokol, Frantisek Nehaj, Jela Ivankova, et al.
Pageof 2